Mission Bio: Roman Haehn

任务简介：罗曼·海恩

Roman Haehn has been appointed as chief commercial officer of Mission Bio, where he will lead the global marketing and commercial teams, business development, sales operations, field applications, and customer support. He joins the company from Agena Bioscience, where he was executive VP and general manager as well as senior VP and chief commercial officer.

Roman Haehn已被任命为Mission Bio的首席商务官，他将领导全球营销和商业团队、业务开发、销售运营、现场应用和客户支持。他从Agena Bioscience加入公司，曾任执行副总裁兼总经理以及高级副总裁兼首席商务官。

Previously, he held leadership roles at Luminex and Ventana Medical Systems..

此前，他曾在Luminex和Ventana Medical Systems担任领导职务。。

Seer: Zachary Crowther

先知：扎卡里·克劳瑟

Proteomics technology company Seer has appointed Zachary Crowther as VP of global marketing. Before joining Seer, Crowther spent eight years at Cepheid, culminating in his role as VP of global product management. Prior to his time at Cepheid, Crowther was at Nanosphere for eleven years where he advanced to the position of director of marketing. Crowther holds a BS degree in biomedical engineering from Northwestern University..

蛋白质组学技术公司Seer任命扎卡里·克罗瑟为全球营销副总裁。在加入Seer之前，克罗瑟在造父变星（Cepheid）工作了八年，最终成为全球产品管理副总裁。在进入造父变星之前，克罗瑟在纳米球工作了11年，并在那里晋升为营销总监。克劳瑟拥有西北大学生物医学工程学士学位。。

Sysmex America: Dan Zortman

Sysmex美国：Dan Zortman

Dan Zortman has been named the CEO of Sysmex America. He replaces Andy Hay who has been the CEO since 2021 and will remain Sysmex America's chairman and president. Zortman has more than 33 years of experience in the diagnostics industry and was most recently VP of commercial operation at Roche. Previously, he was national director of sales and marketing for Roche Canada.

丹·佐特曼被任命为Sysmex America的首席执行官。他接替了自2021年以来一直担任首席执行官的安迪·海（AndyHay），并将继续担任Sysmex America的董事长和总裁。Zortman在诊断行业拥有超过33年的经验，最近担任罗氏商业运营副总裁。。

Before Roche, he worked in sales at Pharmacia Dx, Sanofi Diagnostics, now part of Beckman Coulter, Bio-Rad Laboratories, and Chiron, now part of Siemens..

在罗氏之前，他曾在Pharmacia Dx、赛诺菲诊断（现在是贝克曼库尔特的一部分）、Bio-Rad实验室和凯龙（现在是西门子的一部分）从事销售工作。。

SMi Systems: Stefan Hamill

SMi系统：Stefan Hamill

SMi Systems, a developer of multi-omic single-molecule imaging technology, has appointed Stefan Hamill as VP of strategy. Hamill was formerly a senior analyst at investment banks Numis (now Deutsche Numis) and Peel Hunt. He holds a PhD in Biochemistry from the University of Cambridge.

SMi Systems是多组学单分子成像技术的开发人员，已任命Stefan Hamill为战略副总裁。哈米尔曾是投资银行Numis（现为Deutsche Numis）和Peel Hunt的高级分析师。他拥有剑桥大学生物化学博士学位。

Next Gen Diagnostics: Alexander Sundermann

下一代诊断：亚历山大·桑德曼

Alexander Sundermann has joined Next Gen Diagnostics as director of infection prevention services, a part-time position. He is a researcher in the department of epidemiology at the University of Pittsburgh School of Public Health.

亚历山大·桑德曼（AlexanderSundermann）已加入下一代诊断公司（Next Gen Diagnostics），担任感染预防服务总监，这是一个兼职职位。他是匹兹堡大学公共卫生学院流行病学系的研究员。

For additional recent items on executive appointments, promotions, and departures in the omics and molecular diagnostics space, please see the People in the News page on our website.

有关组学和分子诊断学领域高管任命、晋升和离职的其他最新信息，请参阅我们网站新闻页面上的人物。